P3. 15-21 Real-World Experience of First-Line Afatinib Treatment in Patients with EGFR Mutant Advanced Non-Small Cell Lung Cancer.
Background: Published reports of first-line afatinib treatment efficacy, side-effects and resistance mechanism in the real-world setting are lacking. Method: A retrospective observational study of patients with EGFR mutant advanced non-small cell lung cancer (NSCLC) receiving first-line afatini...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | E-Article |
| Language: | English |
| Published: |
Elsevier
2018
|
| Subjects: | |
| Online Access: | http://ir.unimas.my/id/eprint/22819/1/Real-World%20Experience%20of%20First-Line%20Afatinib.pdf http://ir.unimas.my/id/eprint/22819/ https://www.jto.org/article/S1556-0864(18)32855-7/fulltext |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|